NASDAQ:ESLA | Income Statement | Estrella Immunopharma, Inc.

Complete source-backed income-statement history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.4M$2.08M-$2.08M-$222,092.00-$2.31M-$2.31M-$0.05-$0.0542,997,73342,997,733
2026-03-31$1.4M$2.29M-$2.29M-$2.29M-$2.29M-$0.05-$0.0542,121,07542,121,075
2025-12-31$25,414.00$613,199.00-$613,199.00-$613,199.00-$25.00-$613,174.00-$0.01-$0.01334,183334,183
2025-09-30$4.15M$4.8M-$4.8M-$4.8M-$4.8M-$0.13-$0.1337,096,02437,096,024
2025-06-30$4.66M$5.54M-$5.54M-$5.54M$850.00-$5.54M-$0.15-$0.1536,165,58936,165,589
2025-03-31$1.41M$2.1M-$2.1M-$2.1M$13.00-$2.1M-$0.06-$0.0636,188,29336,188,293
2024-09-30$2.83M$3.38M-$3.38M-$3.38M-$3.38M-$0.09-$0.0936,208,47736,208,477
2024-06-30$3.53M$3.95M-$3.95M-$3.95M$1,625.00-$3.95M-$0.11-$0.1136,376,73836,376,738
2024-03-31$25,000.00$469,530.00-$469,530.00-$469,530.00-$469,530.00-$0.01-$0.0135,519,19235,519,192
2023-12-31$75,459.00$1.02M-$1.02M-$1.02M-$0.03-$0.0335,201,23235,201,232
2023-09-30$483,466.00$1.87M-$1.87M-$1.87M-$1.87M-$1.78-$1.781,052,6561,052,656
2023-06-30$2.58M$2.73M-$2.73M-$54,927.00$21,077.00-$2.73M$3.60$3.6095,93795,937
2023-03-31$2.62M$2.74M-$2.74M-$43,860.00$19,465.00-$2.74M-$8.13-$8.13337,275337,275
2022-12-31$2.61M$2.76M-$2.76M-$69,755.00$80,648.00-$2.76M-$16.33-$16.33168,758168,758
2022-09-30$2.61M$2.89M-$2.89M-$344,863.00$0.00-$2.89M-$34.33-$34.3384,04184,041
2022-06-30-$423,765.00-$359,586.00$0.00-$359,586.00-$0.06-$0.061,419,7001,419,700
2022-03-31-$144,940.00-$141,252.00$0.00-$141,252.00-$0.02-$0.021,419,7001,419,700
2021-12-31-$136,654.00-$135,797.00$0.00-$135,797.0082,82582,825
2021-09-30-$108,114.00-$107,547.00$0.00-$107,547.00-$0.99-$0.991,280,0671,280,067
2021-06-30-$3,559.00-$3,555.00$0.00-$3,555.00$0.00$0.001,000,0001,000,000
2021-03-31-$819.00-$819.00$0.00-$819.00-$2.06$0.001,000,0001,000,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$10.25M$13.06M-$13.06M-$13.06M$838.00-$13.06M-$0.35-$0.3536,820,81036,820,810
2024-06-30$4.11M$7.31M-$7.31M-$7.31M$1,625.00-$7.31M-$0.27-$0.2727,103,96427,103,964
2023-06-30$10.45M$11.11M-$11.11M-$11.11M-$11.11M-$36.35-$36.35305,748305,748
2022-12-31-$1.57M-$915,456.00$80,648.00-$996,104.00
2021-12-31-$249,146.00-$247,718.00$0.00-$247,718.001,179,3281,179,328